Vision-Sciences Inc. (VSCI) Stock Surges on Clearance
Shares of Vision-Sciences Inc. broke a 52-week high Wednesday after the medical device maker received U.S. Food and Drug Administration clearance to market its new line of endoscopes.
The news sent the company's share up 72 cents, or 38.7 percent, to $2.57 in afternoon trading. Earlier in the session, the stock exceeded its 52-week high of $1.89, reaching $3.79 per share.
The company says its new advanced videoscopes will be used to examine patients suffering from various disorders, ranging from difficulty swallowing, difficulty breathing, sleep apnea, asthma, chronic cough, gastroesophageal reflux disease, Barrett's disease and symptoms of cancer.
The news sent the company's share up 72 cents, or 38.7 percent, to $2.57 in afternoon trading. Earlier in the session, the stock exceeded its 52-week high of $1.89, reaching $3.79 per share.
The company says its new advanced videoscopes will be used to examine patients suffering from various disorders, ranging from difficulty swallowing, difficulty breathing, sleep apnea, asthma, chronic cough, gastroesophageal reflux disease, Barrett's disease and symptoms of cancer.
Labels: Vision-Sciences Inc., VSCI
posted by Stock Administrator @ 1:29 PM
0 Comments
